Calidi Biotherapeutics Appoints New CMO, Director
Ticker: CLDWW · Form: 8-K · Filed: Jun 26, 2024 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment, corporate-governance
Related Tickers: CLDI
TL;DR
Calidi Biotherapeutics just hired a new CMO and added a director to the board. Big moves for CLDI.
AI Summary
Calidi Biotherapeutics, Inc. announced on June 20, 2024, the appointment of Dr. Xiaolin Liu as Chief Medical Officer and the election of Dr. Lawrence E. Stern to its Board of Directors. The company also reported on compensatory arrangements for its officers. This follows a name change from First Light Acquisition Group, Inc. on April 6, 2021.
Why It Matters
The appointment of a new Chief Medical Officer and a Board Director signals potential strategic shifts or advancements in the company's clinical development and governance.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can indicate strategic shifts or underlying issues, requiring closer monitoring of the company's direction.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- Dr. Xiaolin Liu (person) — Appointed Chief Medical Officer
- Dr. Lawrence E. Stern (person) — Elected to Board of Directors
- First Light Acquisition Group, Inc. (company) — Former Company Name
- June 20, 2024 (date) — Date of earliest event reported
- April 6, 2021 (date) — Date of name change
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Xiaolin Liu was appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors?
Dr. Lawrence E. Stern has been elected to the Board of Directors.
What was Calidi Biotherapeutics, Inc. formerly known as?
Calidi Biotherapeutics, Inc. was formerly known as First Light Acquisition Group, Inc.
When did the company change its name?
The company changed its name on April 6, 2021.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported is June 20, 2024.
Filing Stats: 815 words · 3 min read · ~3 pages · Grade level 10.2 · Accepted 2024-06-26 16:15:42
Key Financial Figures
- $0.0001 — ch Registered Common stock, par value $0.0001 per share CLDI NYSE American LLC
Filing Documents
- form8-k.htm (8-K) — 45KB
- 0001493152-24-025267.txt ( ) — 261KB
- cldi-20240620.xsd (EX-101.SCH) — 4KB
- cldi-20240620_def.xml (EX-101.DEF) — 26KB
- cldi-20240620_lab.xml (EX-101.LAB) — 36KB
- cldi-20240620_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CALIDI BIOTHERAPEUTICS, INC. Dated: June 26, 2024 By: /s/ Andrew Jackson Name: Andrew Jackson Title: Chief Financial Officer